Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M424Revenue $M0Net Margin (%)-235.6Z-Score0
Enterprise Value $M389EPS $0Operating Margin %-154.9F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-236.3Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsN
Price/Sales19.35-y EBITDA Growth Rate %0Current Ratio0.9Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-58.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.1ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with CHRS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CHRS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CHRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HEALY JAMESDirector 2014-11-12Buy425,926$13.5-3.11view
LILLY ELI & CO 2014-11-12Buy164,963$13.5-3.11view
Herman Alan C.Chief Scientific Officer 2014-11-06Sell0$0-3.11view
Lanfear Dennis MSee Remarks 2014-11-06Sell0$0-3.11view
Troendle August J.Director 2014-11-06Sell0$0-3.11view
HEALY JAMESDirector 2014-11-06Sell0$0-3.11view
Ascena Retail Group, Inc.10% Owner 2012-06-14Sell0$0-3.11view
COOPERMAN LEON G10% Owner 2012-03-28Buy432,600$5.6133.57view
COOPERMAN LEON G10% Owner 2012-02-22Buy291,900$5.21151.06view
GOLDSTEIN MICHAELDirector 2010-10-15Buy10,000$3.51272.65view

Press Releases about CHRS :

    Quarterly/Annual Reports about CHRS:

      News about CHRS:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Coherus BioSciences Reports Third Quarter 2014 Financial and Operating Results Dec 15 2014
      COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Dec 15 2014
      Coherus BioSciences Reports Third Quarter 2014 Financial and Operating Results Dec 15 2014
      Q3 2014 Coherus Biosciences Inc Earnings Release - After Market Close Dec 15 2014
      COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Dec 11 2014
      Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12 Dec 08 2014
      Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12 Dec 08 2014
      KKR to Acquire Minority Stake in Arbor Pharmaceuticals Dec 05 2014
      Coherus BioSciences to Host Earnings Conference Call on December 15 Dec 04 2014
      Coherus BioSciences to Host Earnings Conference Call on December 15 Dec 04 2014
      Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock Nov 19 2014
      Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters'... Nov 19 2014
      COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Nov 13 2014
      Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters'... Nov 12 2014
      Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock Nov 06 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK